05:22 PM EST, 12/27/2024 (MT Newswires) -- Michael Myers, Director, Chief Executive Officer, on December 23, 2024, executed a purchase for 555,556 shares in Quoin Pharmaceuticals ( QNRX ) for $250,000. Following the Form 4 filing with the SEC, Myers has control over a total of 602,808 shares of the company, with 602,808 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1671502/000110465924132188/xslF345X05/tm2431988-3_4seq1.xml